Nexalin Technology (NXL) Common Equity (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Common Equity of $2.9 million for Q1 2026, up 24.12% year-over-year from $2.3 million in Q1 2025, and down 22.99% quarter-over-quarter from $3.7 million in Q4 2025.
Nexalin Technology (NXL) Common Equity (2021 - 2026) Analysis & Trends
Nexalin Technology's Common Equity history runs 6 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Common Equity rose 24.12% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 24.12% YoY), while the FY2025 annual figure was $3.7 million, up 1.96% from the prior year.
- Common Equity for Q1 2026 stood at $2.9 million, down from $3.7 million in the prior quarter.
- The five-year high for Common Equity was $6.4 million in Q3 2022, with the low at -$2.2 million in Q2 2022.
- The 5-year median for Common Equity is $3.7 million (2024), against an average of $3.2 million.
- The sharpest annual moves came in 2022 and 2024: Common Equity jumped 425.74% in 2022, then sank 66.17% in 2024.
- Nexalin Technology's Common Equity stood at $5.5 million in 2022, then slumped by 41.47% to $3.2 million in 2023, then climbed by 14.64% to $3.7 million in 2024, then grew by 1.96% to $3.7 million in 2025, then fell by 22.99% to $2.9 million in 2026.
- Business Quant data shows NXL's Common Equity at $2.9 million in Q1 2026, $3.7 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 5.48 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | -2.24 Mn |
| Mar 31, 2022 | -1.97 Mn |
| Dec 31, 2021 | -1.68 Mn |
| Sep 30, 2021 | -1.97 Mn |